Vascular Endothelial Growth Factor. From base research to clinical application;Il Vascular Endothelial Growth Factor. Dalla ricerca di base all'applicazione clinica

Minerva Medica

Volumn 90, Issue 1-2, 1999, Pages 15-23

  Smirne, C ^a   Camandona, M ^a   Rosso, E ^a   Bellone, G ^a,b   Emanuelli, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b NONE   (Italy)

Author keywords

Dendritic cells; Endothelial cells; Neoangiogenesis; Tumor growth

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANTIGEN PRESENTING CELL; BLOOD VESSEL PERMEABILITY; DENDRITIC CELL; METASTASIS; PANCREAS ADENOCARCINOMA; PATHOPHYSIOLOGY; REVIEW; SOLID TUMOR; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 0033025823     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Hamilton WJ, Boyd JD, Mossman HW. Human Embryology Baltimore: William et Wilkins, 1962
2. Folkman J What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
3. Folkman J, Shing Y. Angiogenesis J Biol Chem 1992. 267:10931-4.
4. Klagsbrun M, D Amore PA. Regulators of angiogenesis. Annu Rev Physiol 1991;53:217-39
5. Risau W. Angiogenesis and endothelial cell function. Arzneimittelforschung 1994;44:416-7.
6. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M et al Abnormal blood vessel developement and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-9.
7. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS et al Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-42
8. Kim KJ, Li B, Houck K, Winer J, Ferrara N. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies Growth Factors 1992.7:53-64.
9. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993;362 841-4.
10. Warren RS, Yuan H, Math MR, Gillett NA, Ferrara N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 1995, 95:1789-97.
11. Kitadai Y, Haruma K, Tokutomi T, Tanaka S, Sumii K, Carvalho M et al Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin Cancer Res 1998;4 2195-200.
12. Vincenti V, Cassano C, Roccht M, Persico G Assignment of the vascular endothelial growth factor gene to the human chromosome 6p21 β Circulation 1996,93.1493-5.
13. Tischer E, Mitchell R, Hartmann T, Silva M, Gospodarowicz D, Fiddes J et al The human gene for vascular endothehal growth factor Multiple protein forms are encoded through alternative exon splicing J Biol Chem 1991.266 11947-54
14. Houck KA, Ferrara N, Winer J, Cachianes G, Li B Leung DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA Mol Endocrinol 1991;5.1806-14
15. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989.246:1306-9.
16. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J et al. Vascular permeability factor, an endothelial cell mitoyen related to platelet derived growth factor. Science 1989,246:1309-12
17. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelia! sjrowth factor family of proteins. Endocr Rev 1992;13: 18-32.
18. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteoiytic mechanisms. J Biol Chem 1992,267:26031-7
19. Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of ECM-bound VEGF. Mol Biol Cell 1993;4:1317-26.
20. Rifkin DB, Moscatelli D, Bizik J, Quarto N, Blei F, Dennis P et al Growth factor control of extracellular proteolysis. Cell Differ Dev 1990;32:313-8.
21. Sreenath T, Matrisian LM, Stetler-Stevenson W, Gattoni-Celli S, Pozzatti RO. Expression of matrix metalloproteinases in transformed rat cell lines of high and low metastatic potential. Cancer Res 1992;52.4942-7.
22. Keyt BA, Berleau LT, Nguyen HV, Heinshon H, Chen H, Vandien R et al The carboxyl-terminal domain (111-165) of VEGF is critical for mitogenic potency. J Biol Chem 1996;271:7788-95.
23. Minchenko A, Bauer T, Sakeda S, Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vitro. Lab Invest 1994;71: 374-9.
24. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359: 843-5
25. Shima DT, Adamis AP, Ferrara N, Yeo KT, Yeo TK, Allende M et al. Hypoxic induction of vascular endothelial cell growth factors in the retina, identification and characterization of vascular endothelial growth factor (VEGF) as the sole mitogen Mol Med 1995;2: 182-93.
26. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994;90:649-52.
27. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16 4604-13.
28. Takagi H, King GL, Robinson GS, Ferrara N, Aiello LP. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pencytes and endothelial cells Invest Opthalmol Vis Sci 1996.37:2165-76.
29. Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme VP. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation Nature 1995.375:577-81.
30. Levy AP, Levy NS, Goldberg MA. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia J Biol Chem 1996;271:2746-53
31. Ikeda E, Achen MG, Breier G, Risau W Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995;270:19761-6.
32. Stein I, Neeman M, Shweiki D, Itin A, Keshet E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 1995,15 5363-8.
33. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG,. Werner S Regulation of VEGF expression in cultured keratinocytes Implications for normal and impaired wound healing. J Biol Chem 1995;270:12607-13.
34. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW et al Overexpression of vascular permeability factor vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994;180:1141-6.
35. Detmar M, Yeo KT, Nagy JA, Van de Water L, Brown LF, Berse B et al. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 1995;105:44-50.
36. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 1995;372:83-7.
37. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996;271-736-41.
38. Warren RS, Yuan H, Math MR, Feirara N, Donner DB. Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J Biol Chem 1996;271 29483-8.
39. Claffey KP, Wilkinson WO, Spiegelman BM. Vascular endothelial growth factor Regulation by cell differentiation and activated second messenger pathways. J Biol Chern 1992;267:16317-22.
40. Kieser A, Weich HA, Brandner G, Marme D, Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994,9:963-9.
41. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T et al. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 1995; 55:4575-80.
42. Grugel S, Finkenzeller G, Weindel K, Barleon B, Marme D. Both v-Ha-Ras and v-Raf stimulate expression of vascular endothelial growth factor in NIH 3T3 cells. J Biol Chem 1995;270.25915-9.
43. Siemester G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marme D. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 1996,56:2299-303.
44. Ihopoulos O, Levy AP, Jiang C, Kaelin WG, Goldberg MA. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 1996;93:10595-9.
45. Larroche JC. Malformations of the nervous system In: Adams JH, Corsellis JAN, Duchen LW, editors. Greenfield's Neuropathology, ed 4. New York: Wiley Medical Publishers, 1984;385-450.
46. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-8.
47. Plouet J, Schilling J, Gospodarowicz D Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells EMBO J 1989,8: 3801-6.
48. Conn G, Bayne M, Soderman L, Kwok PW, Sullivan KA, Palisi TM et al. Amino acid and cDNA sequence of a vascular endothelial cell mitogen homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 1990;87:2628-32.
49. Pepper MS, Wasi S, Ferrara N, Orci L, Montesano R In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Exp Cell Res 1994;210 298-305.
50. Pepper MS, Ferrara N, Orci L, Montesano R Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro Biochem Biophys Res Commun 1992;189:824-31.
51. Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992,153:557-62
52. Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor type 1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991;181:902-8.
53. Pepper MS, Montesano R Procealytic balance and capillary morphogenesis. Cell Differ Dev 1990;32: 319-31
54. Mandriota S, Montesano R, Orci L, Seghezzi G, Vassalli JD, Ferrara N et al Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells J Biol Chem 1995;270:9709-16
55. Mignatti P, Tsuboi R, Robbins E, Rifkin DB In vitro angiogenesis on the human amniotic membrane, requirement for basic fibroblast growth factor-induced proteinases J Cell Biol 1989.108 671-82
56. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219 983-5.
57. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel N et al. Human vascular permeability factor Isolation from U937 cells. J Biol Chem 1989. 254.20017-24.
58. Dvorak HF Tumors: wounds that do not heal. Similarity between tumor stroma generation and wound healing N Engl J Med 1986;315.1650-8.
59. Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM. Fibrin containing gels induce angiogenesis: implications for tumor stroma generation and wound healing. Lab Invest 1987;57:673-86.
60. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995;108: 2369-79.
61. Delhan M, Witwer BP, Salehi HA, Yuan F, Jain RK. Quantitation and physiological characterization of angiogenic vessels in mice. Effects of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am J Pathol 1996;149:59-7:
62. Pekala P, Marlow M, Heuvelman D, Connolly D. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J Biol Chem 1990;265:18051-4
63. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium Nature Med 1996;2:992-7.
64. Sasaki A, Melder RJ, Whiteside TL, Herberman RB, Jain RK Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation. J Natl Cancer Inst 1991.83:433-7
65. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotemonocyte migration J Exp Med 1990,172:1535-45.
66. Broxmeyer HE, Cooper S, Li ZH, Song HY, Kwon BS, Warren RS et al Myeloid progenitor cells regulatory effects of vascular endothelial growth factor Int J Hematol 1995;62:203-15
67. Ku DD, Zaleski JK, Liu S, Brock T Vascular endothelial growth factor induces EDRF-dependent relaxation of coronary arteries. Am J Physiol 1993;265:H586-92.
68. Yang R, Thomas GR, Bunting S, Ko A, Keyt B, Ferrara N et al Effects of VEGF on hemodynamics and cardiac performance. J Cardiovasc Pharmacol 1996;27:838-44.
69. Vaisman N, Gospodarowicz D, Neufeld G. Characterization of the receptors for vascular endothelial growth factor. J Biochem 1990;265-19461-9.
70. Jakeman LB, Winer J, Bennett GL, Altar CA, Ferrara N. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 1992:89-244-53.
71. Jakeman LB, Armanini M, Phillips HS, Ferrara N. Developmental expression of binding sites and mRNA for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 1993,133.848-59.
72. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit Proc Natl Acad Sci USA 1991.88 9026-30.
73. deVries C, Escobedo JA, Ueno H, Houck KA, Ferrara N, Williams LT. The fins-like tyrosine kinase, a receptor for vascular endothelial growth faaor. Science 1992;255: 989-91.
74. Terman BI, Vermazen MD, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor Biochem Biophys Res Commun 1992;34 1578-86
75. Shibuya M, Yamaguchi S, Yamane A, Ikada T, Toio T, Matsushime H et al Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) closely related to the fms family. Oncogene 1990;8: 519-27.
76. Kendall RL, Thomas KA Inhibition of vascular endothelial growth factor by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993,90: 10705-9.
77. Shen H, Clauss M, Ryan J, Schmidt AM, Tijburg P, Borden L et al. Characterization of vascular permeability factor vascular endothelial growth factor receptors in mononuclear phagocytes. Blood 1993.81:2767-73.
78. Guo D, Jia Q, Song HY, Warren RS, Donner D. Vascular endothelial growth factor promotes tyrosine phosphorytation of mediators of signal transduction that contain SH2 domains Association with endothelial cell proliferation. J Biol Chem 1995.270.6729-33
79. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor J Biol Chem 1994,269:26988-95
80. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M. A unique signal transduction pathway for the Flt tyrosine kinase, a receptor for vascular endothelial growth factor Oncogene 1995,10 135-47.
81. Barleon B, Sozzani S, Zhou D, Weich H, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor Flt-1. Blood 1996.87. 3336-43.
82. Tuder RM, Flook BE, Voelkel NF Increased gene expression for VEGF and the VEGF receptors KDR Flk and Flt in lungs exposed to acute or chronic hypoxia J Clin Invest 1995,95:1798-807
83. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B et al. Hypoxia-mduced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 1996;97-469-76.
84. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993;53:4727-35.
85. Ferrara N, Winer J, Burton T, Rowland A, Siegel M, Phillips HS et al Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest 1993;91:160-70.
86. Erroi A, Sironi M, Chiaffanno F, Chen ZG, Mengozzi M, Mantovani A. IL1 and IL6 released by tumor-associated macrophages from human ovarian carcinoma Int. J. Cancer 1989;44:795-801.
87. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alfa cooperate in the generation of dendritic cells. Nature 1992;360:258-61.
88. Gabrilovich DI, Chen HL, Girgis KR, Cunningam HT, Meny GM, Nadaf S et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med 1996,2.1096-103.
89. Mayordomo JI et al. Bone marrow-derived dendritic cells pulsed with synthetic rumour peptides elicit protective and therapeutic antitumour immunity. Nature Med 1995,1.1297-302.
90. Asano M, Yukita A, Matsumoto T, kondo S, Suzuki H. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth/vascular permeability factor Cancer Res 1995;55.5296-301.
91. Hori A, Sasada R, Matsutani E, Naito K, Sakura Y, Fujita T et al. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor Cancer Res 1991;51: 6180-1.
92. O'Reilly MS Boehm T, Shing Y, Fukai N, Vasios G, Lane Ws et al Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88.277-85.
93. O Reilly MS. Angiostatin: an endogenous inhibitor of angiogenesis and tumor growth. EXS 1997;79:273-94.
94. Wu Z, O'Reilly MS, Folkman J, Shing Y. Suppression of tumor growth with recombinant murine angiostatin. Biochem Biophys Res Commun 1997;236:651-4.
95. Sim BK, O'Reilly MS, Liang H, Fortier AH, He W, Madsen JW et al A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res 1997;57:1329-34.
96. Cheng Sy, Huang HJ, Nagane M, Ji XD, Wang D, Shin CC et al Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of VEGF. Proc Natl Acad Sci USA 1996;93:8502-7.
97. Ellis LM, Liu W, Wilson M. Down-regulation of VEGF in human colon carcinoma cells by antisense transfection decreases endothelial cell proliferation. Surgery 1996;120:871-8.
98. Kong HL, Crystal RG. Gene therapy strategies for tumor antiangiogenesis. J Natl Cancer Inst. 1998;90: 273-86.
99. Konno H, Tanaka T, Kanai T, Baba S Therapeutic effect of angiogenesis inhibitors on liver metastases of human colorectal carcinoma. Nippon Geka Gakkai Zasshi 1998,99:441-5.
100. Kawarada Y, Ishikura H, Kishimoto T, Saito K, Takahashi T, Kato H et al. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo. Pancreas 1997;15:251-7.